Conmed Corp
NYSE:CNMD

Watchlist Manager
Conmed Corp Logo
Conmed Corp
NYSE:CNMD
Watchlist
Price: 39.8475 USD 1.96%
Market Cap: $1.2B

Conmed Corp
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Conmed Corp
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Conmed Corp
NYSE:CNMD
Total Current Liabilities
$315m
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Total Current Liabilities
$5.4B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%
Edwards Lifesciences Corp
NYSE:EW
Total Current Liabilities
$1.8B
CAGR 3-Years
21%
CAGR 5-Years
15%
CAGR 10-Years
14%
Stryker Corp
NYSE:SYK
Total Current Liabilities
$7.8B
CAGR 3-Years
7%
CAGR 5-Years
9%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Total Current Liabilities
$16.5B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Current Liabilities
$2B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
15%
No Stocks Found

Conmed Corp
Glance View

Conmed Corporation, founded in the small city of Utica, New York, has carved a niche for itself in the competitive world of medical technology. The company, which began its journey in the mid-1970s, has evolved into a global player by specializing in a variety of surgical and patient care products. At its core, Conmed thrives on its deep expertise in the design and manufacturing of surgical instruments used predominantly in minimally invasive procedures. These include sophisticated medical devices for orthopedic, laparoscopic, robotic, and general surgeries. Conmed’s strategic focus has always been on innovation, driven by a commitment to enhance the surgeon's ability to provide superior patient care, which is evident in their continuous research and development efforts aimed at creating more efficient and effective tools for medical professionals. The revenue streams for Conmed are as diversified as their product offerings. By selling advanced surgical equipment and medical products to hospitals, surgical centers, and outpatient facilities worldwide, Conmed positions itself as a critical supplier in the healthcare industry. A significant portion of their income is derived from the repeat sales of disposable items and replacement parts required for these high-tech devices. This creates a continuous cycle of revenue through both initial capital sales and recurring sales of consumables, quintessential for sustaining robust financial stability. Furthermore, the company's growth strategy has been marked by strategic acquisitions, allowing it to broaden its array of products and enter new markets, thereby ensuring its continued prominence and adaptability in the ever-evolving landscape of healthcare technology.

CNMD Intrinsic Value
84.4405 USD
Undervaluation 53%
Intrinsic Value
Price $39.8475

See Also

What is Conmed Corp's Total Current Liabilities?
Total Current Liabilities
315m USD

Based on the financial report for Dec 31, 2025, Conmed Corp's Total Current Liabilities amounts to 315m USD.

What is Conmed Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
10%

Over the last year, the Total Current Liabilities growth was 13%. The average annual Total Current Liabilities growth rates for Conmed Corp have been 2% over the past three years , 11% over the past five years , and 10% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett